Principal Securities, Inc. Sarepta Therapeutics, Inc. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 225 shares of SRPT stock, worth $24,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225
Previous 1,146
80.37%
Holding current value
$24,862
Previous $181 Million
84.48%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$991 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$692 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$482 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$472 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...